Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.
Department of Anesthesia, University of Toronto, Toronto, ON, Canada.
Crit Care Med. 2018 Feb;46(2):300-306. doi: 10.1097/CCM.0000000000002838.
A recent post hoc analysis suggested that driving pressure may be more important than traditional ventilatory variables in determining outcome in mechanically ventilated patients with acute respiratory distress syndrome. We conducted a systematic review and meta-analysis to summarize the risk of mortality for higher versus lower driving pressure.
MEDLINE, EMBASE, PubMed, CINAHL, and Cochrane CENTRAL from inception to February 10, 2017.
Studies including mechanically ventilated adult patients with acute respiratory distress syndrome, reporting driving pressure and mortality.
Seven studies including five secondary analysis of previous randomized controlled trials and two observational studies (6,062 patients) were eligible for study. All studies were judged as having a low risk of bias. Median (interquartile range) driving pressure between higher and lower driving pressure groups was 15 cm H2O (14-16 cm H2O). Median (interquartile range) mortality of all included studies was 34% (32-38%).
In the meta-analyses of four studies (3,252 patients), higher driving pressure was associated with a significantly higher mortality (pooled risk ratio, 1.44; 95% [CI], 1.11-1.88; I = 85%). A sensitivity analysis restricted to the three studies with similar driving pressure cutoffs (13-15 cm H2O) demonstrated similar results (pooled risk ratio, 1.28; 95% CI, 1.14-1.43; I = 0%).
Our study confirmed an association between higher driving pressure and higher mortality in mechanically ventilated patients with acute respiratory distress syndrome. These findings suggest a possible range of driving pressure to be evaluated in clinical trials. Future research is needed to ascertain the benefit of ventilatory strategies targeting driving pressure in patients with acute respiratory distress syndrome.
最近的事后分析表明,在机械通气治疗急性呼吸窘迫综合征患者中,驱动压可能比传统通气变量更能决定预后。我们进行了一项系统评价和荟萃分析,以总结较高与较低驱动压与死亡率之间的关系。
从建库到 2017 年 2 月 10 日,检索 MEDLINE、EMBASE、PubMed、CINAHL 和 Cochrane CENTRAL。
纳入了机械通气治疗的急性呼吸窘迫综合征成年患者,报告了驱动压和死亡率。
有 7 项研究(包括 5 项先前随机对照试验的二次分析和 2 项观察性研究)符合纳入标准,共纳入 6062 例患者。所有研究均被判定为低偏倚风险。较高与较低驱动压组之间的中位(四分位间距)驱动压为 15cmH2O(14-16cmH2O)。所有纳入研究的中位(四分位间距)死亡率为 34%(32-38%)。
在 4 项研究(3252 例患者)的荟萃分析中,较高的驱动压与死亡率显著升高相关(合并风险比 1.44;95%CI 1.11-1.88;I = 85%)。敏感性分析限制于驱动压截断值相似的 3 项研究(13-15cmH2O),结果类似(合并风险比 1.28;95%CI 1.14-1.43;I = 0%)。
本研究证实了机械通气治疗急性呼吸窘迫综合征患者中,较高的驱动压与较高的死亡率相关。这些发现提示在临床试验中可能需要评估一个驱动压范围。需要进一步研究以确定针对急性呼吸窘迫综合征患者的驱动压通气策略的获益。